A detailed history of Nisa Investment Advisors, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 80 shares of RARE stock, worth $3,365. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80
Previous 80 -0.0%
Holding current value
$3,365
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$37.35 - $52.15 $4,855 - $6,779
-130 Reduced 61.9%
80 $3,000
Q3 2022

Nov 07, 2022

SELL
$39.96 - $66.14 $332,587 - $550,483
-8,323 Reduced 97.54%
210 $8,000
Q2 2022

Aug 03, 2022

BUY
$45.8 - $85.4 $370,980 - $691,740
8,100 Added 1870.67%
8,533 $509,000
Q1 2022

Apr 29, 2022

SELL
$62.2 - $84.4 $86,831 - $117,822
-1,396 Reduced 76.33%
433 $31,000
Q4 2021

Feb 03, 2022

BUY
$73.71 - $87.86 $9,361 - $11,158
127 Added 7.46%
1,829 $128,000
Q3 2021

Oct 18, 2021

SELL
$77.92 - $102.4 $161,294 - $211,968
-2,070 Reduced 54.88%
1,702 $154,000
Q2 2021

Aug 06, 2021

SELL
$92.19 - $115.71 $133,675 - $167,779
-1,450 Reduced 27.77%
3,772 $360,000
Q4 2020

Jan 25, 2021

BUY
$84.4 - $177.39 $281,642 - $591,950
3,337 Added 177.03%
5,222 $723,000
Q3 2020

Oct 20, 2020

BUY
$72.98 - $90.0 $105,821 - $130,500
1,450 Added 333.33%
1,885 $155,000
Q2 2020

Jul 27, 2020

BUY
$46.91 - $78.22 $2,345 - $3,911
50 Added 12.99%
435 $34,000
Q1 2020

Apr 17, 2020

BUY
$33.8 - $62.9 $3,379 - $6,290
100 Added 35.09%
385 $17,000
Q3 2019

Oct 17, 2019

BUY
$42.5 - $63.11 $2,975 - $4,417
70 Added 32.56%
285 $12,000
Q3 2018

Oct 16, 2018

SELL
$71.81 - $90.15 $4,308 - $5,409
-60 Reduced 21.82%
215 $16,000
Q2 2018

Jul 19, 2018

BUY
$48.54 - $85.31 $4,854 - $8,531
100 Added 57.14%
275 $21,000
Q1 2018

Apr 10, 2018

BUY
$44.33 - $58.52 $7,757 - $10,241
175 New
175 $9,000

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $2.95B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.